The effects of Salvia przewalskii total phenolic acid extract on immune complex glomerulonephritis

References

• Beitollahi H, Hamzavi M, Torkzadeh-Mahani M. 2015. Electrochemical determination of hydrochlorothiazide and folic acid in real samples using a modified graphene oxide sheet paste electrode. Mater Sci Eng C Mater Biol Appl. 52:297–305.
   PubMed Web of Science ®Google Scholar
• Chen WS, Tao ZY, Zhang WD, Sun LN. 2003. A new compound from the root of Salvia przewalskii Maxim. Chin Chem Lett. 14:711–712.
   Web of Science ®Google Scholar
• Cheng QL, Orikasa M, Morioka T, Kawachi H, Chen XM, Oite T, Shimizu F. 1995. Progressive renal lesions induced by administration of monoclonal antibody 1-22-3 to unilaterally nephrectomized rats. Clin Exp Immunol. 102:181–185.
   PubMed Web of Science ®Google Scholar
• Cheng TJ, Yang ZY. 2003. Comparison between S. przewalskii Maxim injection and S. miltiorrhiza Bunge injection on the protection on acute focal cerebral ischemia of rats and the effect against lipid peroxidation. Chin J Clin Pharmacol Ther. 8:23–26.
   Google Scholar
• Cheng Y, Zhang JB, Hou WP, Wang DH, Li FR, Zhang YQ, Yuan FH. 2009. Immunoregulatory effects of sinomenine on the T-bet/GATA-3 ratio and Th1/Th2 cytokine balance in the treatment of mesangial proliferative nephritis. Int Immunopharmacol. 9:894–899.
   PubMed Web of Science ®Google Scholar
• Dai DS, Liu X, Yang Y, Luo XM, Tang RX, Yin ZC, Ren HQ. 2015. Protective effect of Salvia przewalskii extract on puromycin-induced podocyte injury. Am J Nephrol. 42:216–227.
   PubMed Web of Science ®Google Scholar
• Danilewicz M, Wągrowska-Danilewicz M. 2001. Morphometric comparison of the quantity of the mesangial deposits in rebiopsied patients with idiopathic mesangial proliferative glomerulonephritis. Pathol Res Pract. 197:545–550.
   PubMed Web of Science ®Google Scholar
• Englberger W, Hadding U, Etschenberg E, Graf E, Leyck S, Winkelmann J, Parnham MJ. 1988. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity. Int J Immunopharmacol. 10:729–737.
   PubMed Web of Science ®Google Scholar
• Fujita M, Iida H, Asaka M, Izumino K, Takata M, Sasayama S. 1991. Effect of the immunosuppressive agent, ciclosporin, on experimental immune complex glomerulonephritis in rats. Nephron. 57:201–205.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Inoue I, Inagi R, Miyata T, Shinzato T, Sugiyama S, Miyama A, Maeda K. 1993. Inhibitory effect of FUT-175 on complement activation and its application for glomerulonephritis with hypocomplementemia. Nihon Jinzo Gakkai Shi. 35:393–397.
   PubMedGoogle Scholar
• Gómez-Guerrero C, Duque N, Casado MT, Pastor C, Blanco J, Mampaso F, Vivanco F, Egido J. 2000. Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis. J Immunol. 164:2092–2101.
   PubMed Web of Science ®Google Scholar
• Gracza L, Koch H, Löffler E. 1985. Über biochemisch-pharmakologische untersuchungen pflanzlicher arzneistoffe, 1. mitt. isolierung von rosmarinsäure aus Symphytum officinale und ihre anti-inflammatorische wirksamkeit in einem in-vitro-modell. Arch Pharm Pharm Med Chem. 318:1090–1095.
   PubMed Web of Science ®Google Scholar
• Huang YQ, Sun XC. 1977. Salvia Linn. In: Wu ZY, Li XW, editors. Flora Reipublicae Popularis Sinicae, vol. 66. Beijing: Science Press; p. 70–79, 86–89.
   Google Scholar
• Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. 1993. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest. 92:2597–2601.
   PubMed Web of Science ®Google Scholar
• Jia H, Zou WZ. 1996. An improved animal model for mesangioproliferative giomerulonephritis in rat. Chin J Nephrol Dialy Transplant. 5:21–25.
   Google Scholar
• Jiang HL, Wang XZ, Xiao J, Luo XH, Yao XJ, Zhao YY, Chen YJ, Crews P, Wu QX. 2013. New abietane diterpenoids from the roots of Salvia przewalskii. Tetrahedron. 69:6687–6692.
   Google Scholar
• Jiang WL, Chen XG, Qu GW, Yue XD, Zhu HB, Tian JW, Fu FH. 2009. Rosmarinic acid protects against experimental sepsis by inhibiting proinflammatory factor release and ameliorating hemodynamics. Shock. 32:608–613.
   PubMed Web of Science ®Google Scholar
• Kang ES, Lee GT, Kim BS, Kim CH, Seo GH, Han SJ, Hur KY, Ahn CW, Ha H, Jung M, et al. 2008. Lithospermic acid B ameliorates the development of diabetic nephropathy in OLETF rats. Eur J Pharmacol. 579:418–425.
   PubMed Web of Science ®Google Scholar
• Kasap B, Türkmen M, Sarıoğlu S, Sis B, Soylu A, Kavukçu S. 2008. The relation of IgM deposition to clinical parameters and histomorphometry in childhood mesangial proliferative glomerulonephritis. Pathol Res Pract. 204:149–153.
   PubMed Web of Science ®Google Scholar
• Lamien-Meda A, Nell M, Lohwasser U, Börner A, Franz C, Novak J. 2010. Investigation of antioxidant and rosmarinic acid variation in the sage collection of the genebank in Gatersleben. J Agric Food Chem. 58:3813–3819.
   PubMed Web of Science ®Google Scholar
• Lee GT, Ha H, Jung M, Li H, Hong SW, Cha BS, Lee HC, Cho YD. 2003. Delayed treatment with lithospermate B attenuates experimental diabetic renal injury. J Am Soc Nephrol. 14:709–720.
   PubMed Web of Science ®Google Scholar
• Lee J, Jung E, Koh J, Kim YS, Park D. 2008. Effect of rosmarinic acid on atopic dermatitis. J Dermatol. 35:768–771.
   PubMed Web of Science ®Google Scholar
• Li LS, Liu ZH. 2003. Experiences in nephritis treated by Tripterygium wilfordii Hook. f. in the 25 years. Chin J Nephrol Dialy Transplant. 12:246–247.
   Google Scholar
• Li LS. 1989. An overview of nephrology in China. Chin Med J. 102:488–495.
   PubMed Web of Science ®Google Scholar
• Li MH, Chen JM, Peng Y, Xiao PG. 2008. Distribution of phenolic acids in Chinese Salvia plants. World Sci Technol – Mod Tradit Chin Med Mater Med. 10:46–52.
   Google Scholar
• Liu JM, Nan P, Tsering Q, Tsering T, Bai ZK, Wang L, Liu ZJ, Zhong Y. 2006. Volatile constituents of the leaves and flowers of Salvia przewalskii Maxim. from Tibet. Flavour Frag J. 21:435–438.
   Web of Science ®Google Scholar
• Lu XZ, Xu WH, Shen JX, Naoki H. 1991. Przewalskinic acid A, a new phenolic acid from Salvia przewalskii Maxim. Chin Chem Lett. 2:301–302.
   Google Scholar
• Makino T, Ono T, Liu N, Nakamura T, Muso E, Honda G. 2002. Suppressive effects of rosmarinic acid on mesangioproliferative glomerulonephritis in rats. Nephron. 92:898–904.
   PubMed Web of Science ®Google Scholar
• Makino T, Ono T, Muso E, Yoshida H, Honda G, Sasayama S. 2000. Inhibitory effects of rosmarinic acid on the proliferation of cultured murine mesangial cells. Nephrol Dial Transplant. 15:1140–1145.
   PubMed Web of Science ®Google Scholar
• Maxie MG, Newman SJ. 2007. Urinary system. In: Maxie MG, editor. Jubb, Kennedy, and Palmer’s pathology of domestic animals, vol. 2, 5th ed. New York, Edinburgh: Elsevier Saunders; p. 451–466.
   Google Scholar
• Ohsaki A, Kawamata S, Ozawa M, Kishida A, Gong X, Kuroda C. 2011. Salviskinone A, a diterpene with a new skeleton from Salvia przewalskii. Tetrahedron Lett. 52:1375–1377.
   Web of Science ®Google Scholar
• Parnham MJ, Kesselring K. 1985. Rosmarinic acid. Drugs Fut. 10:756–757.
   Google Scholar
• Petersen M, Simmonds MSJ. 2003. Rosmarinic acid. Phytochemistry. 62:121–125.
   PubMed Web of Science ®Google Scholar
• Qing DH, Chen HS, Peng ZG, Guo ZM. 2004. A new compound from Salvia przewalskii and its anti-HIV effect. Chin Tradit Herb Drugs. 35:725–728.
   Google Scholar
• Sahu A, Rawal N, Pangburn MK. 1999. Inhibition of complement by covalent attachment of rosmarinic acid to activated C3b. Biochem Pharmacol. 57:1439–1446.
   PubMed Web of Science ®Google Scholar
• Sánchez-Campillo M, Gabaldon JA, Castillo J, Benavente-García O, Del Baño MJ, Alcaraz M, Vicente V, Alvarez N, Lozano JA. 2009. Rosmarinic acid, a photo-protective agent against UV and other ionizing radiations. Food Chem Toxicol. 47:386–392.
   PubMed Web of Science ®Google Scholar
• Skała E, Wysokińska H. 2005. Tanshinone production in roots of micropropagated Salvia przewalskii Maxim. Z Naturforsch C. 60:583–586.
   PubMed Web of Science ®Google Scholar
• Wan YG, Sun W, Zhen YJ, Che XY, Pu HP, Wang Y, Li M, Ruan JG, Yan QJ. 2011. Multi-glycoside of Tripterygium wilfordii Hook. f. reduces proteinuria through improving podocyte slit diaphragm dysfunction in anti-Thy1.1 glomerulonephritis. J Ethnopharmacol. 136:322–333.
   PubMed Web of Science ®Google Scholar
• Wang HQ, Yang LX, Chen XY, Yang PF, Chen RY. 2015. Chemical constituents from Salvia przewalskii root. J Chin Med Mater. 38:1197–1201.
   Google Scholar
• Wang N, Niwa M, Luo HW. 1988. Triterpenoids from Salvia przewalskii. Phytochemistry. 27:299–301.
   Web of Science ®Google Scholar
• Wu ZJ, Ouyang MA, Yang CR. 1999. Polyphenolic constituents of Salvia przewalskii. Acta Bot Yunnanica. 21:512–516.
   Google Scholar
• Xue YB, Wu Y, Zhu HC, Li XN, Qian JF, Lai YJ, Chen CM, Yao GM, Luo ZW, Li Y, et al. 2014. Salviprzols A and B, C21- and C22-terpenoids from the roots of Salvia przewalskii Maxim. Fitoterapia. 99:204–210.
   PubMed Web of Science ®Google Scholar
• Yang Y, Bing Z, Sun LN, Wu ZJ, Chen WS. 2013. Chemical constituents of Salvia przewalskii Maxim. Asian J Chem. 25:1747–1748.
   Google Scholar
• Yang Y, Lu WQ, Wu ZJ, Chen WS. 2017. A new diterpenoid from Salvia przewalskii. Rec Nat Prod. 11:416–420.
   Google Scholar
• Yang Y, Wu ZJ, Yang YB, Lai W, Sun LN, Chen WS. 2011. Three new terpenoids from Salvia przewalskii Maxim. Chem J Chin Univ. 32:1318–1322.
   Web of Science ®Google Scholar
• Yang Y, Zhang F, Cai F, Sun LN, Chen WS. 2008. Advances in studies on chemical constituents and pharmacological effects of Salvia przewalskii Maxim. J Chin Med Mater. 31:787–790.
   Google Scholar
• Yang Y, Zhu B, Wu ZJ, Chen WS, Sun LN. 2012. Effects of Salvia przewalskii Maxim. extract on whole blood viscosity in normal rats and its diuresis in water-loaded rat. Chin J Hosp Pharm. 32:751–754.
   Google Scholar
• Yao G, Xu LZ, Wu XC, Xu LL, Yang JW, Chen HM. 2009. Preventive effects of salvianolic acid B on transforming growth factor-beta1-induced epithelial-to-mesenchymal transition of human kidney cells. Biol Pharm Bull. 32:882–886.
   PubMed Web of Science ®Google Scholar